Observational studyJournal of diabetes investigation2021

Sodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes.

Koki Chiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.